PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment
Projects
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer’s Guides
Partner Content
Pricing and Market Access
Events
Reports
Premium Insights
Excellence Awards
Magazine
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Transforming MedTech and Pharma using Software as a Medical Device (SaMD)
Accelerating Biopharmaceutical Innovation
Accelerating Clinical Trials
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
Specialty drug launch strategy and operations
The next chapter of clinical trial services
Future Pharma Services
Putting quality first in the pharma supply chain
Enabling better biopharmaceutical manufacturing
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment
Projects
Latest
Illegal online pharmacies gain traction as regulators lag behind
After 2022 interest rate hikes spook investors, pharma M&A to resurge in late 2023
Excitement associated with FDA approval of Rinvoq in Crohn’s disease
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Latest
Touchlight boosts DNA manufacturing capacity with latest expansion
After 2022 interest rate hikes spook investors, pharma M&A to resurge in late 2023
Daiichi Sankyo receives Japan’s MHLW approval for VANFLYTA
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
ICR and Royal Marsden NHS Foundation Trust open new integrated pathology unit
Sanofi deploys Veeva Systems’ solutions to improve quality management
Recursion plans $87.5m acquisitions to shore up AI drug discovery
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Who’s innovating where? Environmental sustainability related patent filings activity decreased by 23% in the pharmaceutical industry in Q1 2023
Who’s hiring who? Social Responsibility hiring activity decreased by 38% in the pharmaceutical industry in Q1 2023
Takeda reports 12.8% rise in FY2022 revenue
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer’s Guides
Partner Content
Latest
Medicines adherence: Overcoming pharma’s biggest barrier to treatment success
Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective
Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective
Events
Reports
Premium Insights
PT
All articles by Imogen Clegg
Imogen Clegg
Research Reports
Pharma executives have faith in AI to solve the R&D optimization puzzle, says GlobalData
Research Reports
Multiple sclerosis market to reach $32.9bn in 2028 driven by launch of pipeline agents, says GlobalData
Research Reports
Pharma industry is prioritizing big data, blockchain, cloud computing and cybersecurity for investments, according to survey by GlobalData
Research Reports
Reproductive Hormones and Protein Tests on the rise, says GlobalData
Research Reports
Huge unmet needs in glioblastoma multiforme market drives the future, says GlobalData
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Subscribe
Research Reports
As prevalent cases of Multiple Sclerosis grow, new investment opportunities open up, says GlobalData
Research Reports
Global medical marijuana market set to reach US$3.2bn by 2025, says GlobalData
Research Reports
Biomarkers will play a key role in shaping the global CNS drug market, although cost remains a limiting factor, says GlobalData
Research Reports
More and more people take seasonal influenza vaccinations, says GlobalData
Research Reports
Global allergic rhinitis immunotherapy market set to reach $1.14bn by 2028, driven by growth in the US and Japan, says GlobalData
View more
Most Popular
FDA awards full approval to Paxlovid amidst hazy coverage plans
Immuno-oncology market set to grow in billions, but access concerns remain
Touchlight boosts DNA manufacturing capacity with latest expansion